• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类雌激素受体具有两种独立的非酸性转录激活功能。

The human estrogen receptor has two independent nonacidic transcriptional activation functions.

作者信息

Tora L, White J, Brou C, Tasset D, Webster N, Scheer E, Chambon P

机构信息

Laboratoire de Génétique Moléculaire des Eucaryotes du CNRS, Unité 184 de Biologie Moléculaire et de Génie Génétique de l'INSERM Institut de Chimie Biologique, Faculté de Médecine, Strasbourg, France.

出版信息

Cell. 1989 Nov 3;59(3):477-87. doi: 10.1016/0092-8674(89)90031-7.

DOI:10.1016/0092-8674(89)90031-7
PMID:2805068
Abstract

We have previously reported the presence of a hormone-inducible transcriptional activation function (TAF-2) within the region of the estrogen receptor (ER) that contains the hormone binding domain. We show here that the N-terminal A/B region of the ER contains an independent constitutive activation function (TAF-1) that exhibits cell type specificity since it activates transcription efficiently in chicken embryo fibroblasts, but only poorly in HeLa cells. By analyzing the ability of TAF-1, TAF-2, and the GAL4 and VP16 acidic activating domains (AADs) to homosynergize and heterosynergize with one another and with the factor binding to the upstream element (UE) of the adenovirus 2 major late promoter, we show that the activation properties of TAF-1 and TAF-2 are different and distinct from those of AADs, in agreement with the absence of acidic amino acid stretches in TAF-1 and TAF-2.

摘要

我们之前报道过,在雌激素受体(ER)包含激素结合结构域的区域内存在一种激素诱导的转录激活功能(TAF-2)。我们在此表明,ER的N端A/B区域包含一种独立的组成型激活功能(TAF-1),该功能具有细胞类型特异性,因为它在鸡胚成纤维细胞中能有效激活转录,但在HeLa细胞中激活效率很低。通过分析TAF-1、TAF-2以及GAL4和VP16酸性激活结构域(AAD)彼此之间以及与结合腺病毒2主要晚期启动子上游元件(UE)的因子进行同源协同和异源协同的能力,我们发现TAF-1和TAF-2的激活特性与AAD不同,这与TAF-1和TAF-2中不存在酸性氨基酸序列一致。

相似文献

1
The human estrogen receptor has two independent nonacidic transcriptional activation functions.人类雌激素受体具有两种独立的非酸性转录激活功能。
Cell. 1989 Nov 3;59(3):477-87. doi: 10.1016/0092-8674(89)90031-7.
2
Distinct classes of transcriptional activating domains function by different mechanisms.不同类别的转录激活结构域通过不同机制发挥作用。
Cell. 1990 Sep 21;62(6):1177-87. doi: 10.1016/0092-8674(90)90394-t.
3
Different TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL-VP16 and the two nonacidic activation functions of the estrogen receptor.不同的TBP相关因子是介导酸性反式激活因子GAL-VP16以及雌激素受体的两种非酸性激活功能在体外对转录进行刺激所必需的。
Nucleic Acids Res. 1993 Jan 11;21(1):5-12. doi: 10.1093/nar/21.1.5.
4
Identification of an estrogen response element upstream of the human c-fos gene that binds the estrogen receptor and the AP-1 transcription factor.
Nucleic Acids Res. 1990 Sep 11;18(17):5097-106. doi: 10.1093/nar/18.17.5097.
5
Promoter specificity of the two transcriptional activation functions of the human oestrogen receptor in yeast.人雌激素受体的两种转录激活功能在酵母中的启动子特异性
Nucleic Acids Res. 1992 Jun 11;20(11):2813-7. doi: 10.1093/nar/20.11.2813.
6
Superactive estrogen receptors. Potent activators of gene expression.超活性雌激素受体。基因表达的强效激活剂。
J Biol Chem. 1990 Jul 15;265(20):11517-21.
7
Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.雌二醇和蛋白激酶激活剂对雌激素受体介导转录的协同激活作用。
Mol Endocrinol. 1993 Mar;7(3):441-52. doi: 10.1210/mend.7.3.7683375.
8
The yeast UASG is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator.在存在GAL4反式激活因子的情况下,酵母UASG在人宫颈癌细胞(HeLa细胞)中是一种转录增强子。
Cell. 1988 Jan 29;52(2):169-78. doi: 10.1016/0092-8674(88)90505-3.
9
Cooperation between the human estrogen receptor (ER) and MCF-7 cell-specific transcription factors elicits high activity of an estrogen-inducible enhancer from the trout ER gene promoter.人类雌激素受体(ER)与MCF-7细胞特异性转录因子之间的合作引发了来自鳟鱼ER基因启动子的雌激素诱导增强子的高活性。
Mol Endocrinol. 1996 Sep;10(9):1116-26. doi: 10.1210/mend.10.9.8885246.
10
Role of the two activating domains of the oestrogen receptor in the cell-type and promoter-context dependent agonistic activity of the anti-oestrogen 4-hydroxytamoxifen.雌激素受体的两个激活结构域在抗雌激素4-羟基他莫昔芬的细胞类型和启动子背景依赖性激动活性中的作用。
EMBO J. 1990 Sep;9(9):2811-8. doi: 10.1002/j.1460-2075.1990.tb07469.x.

引用本文的文献

1
Targeting the ERα DBD-LBD interface with mitoxantrone disrupts receptor function through proteasomal degradation.用米托蒽醌靶向雌激素受体α的DNA结合结构域-配体结合结构域界面,通过蛋白酶体降解破坏受体功能。
Mol Cancer Ther. 2025 Sep 11. doi: 10.1158/1535-7163.MCT-25-0405.
2
Expression Dynamics and Estrogen Response of Estrogen Receptors in Duolang Sheep During Puberty.多浪羊青春期雌激素受体的表达动态及雌激素反应
Genes (Basel). 2025 Jun 24;16(7):731. doi: 10.3390/genes16070731.
3
Zooming into Gene Activation: Estrogen Receptor α Dimerization and DNA Binding Visualized by High-Speed Atomic Force Microscopy.
深入探究基因激活:通过高速原子力显微镜观察雌激素受体α二聚化和DNA结合
ACS Nano. 2025 Apr 29;19(16):15395-15410. doi: 10.1021/acsnano.4c14943. Epub 2025 Apr 18.
4
Endocrine treatment mechanisms in triple-positive breast cancer: from targeted therapies to advances in precision medicine.三阳性乳腺癌的内分泌治疗机制:从靶向治疗到精准医学的进展
Front Oncol. 2025 Jan 7;14:1467033. doi: 10.3389/fonc.2024.1467033. eCollection 2024.
5
Hormone Signaling in Breast Development and Cancer.乳腺发育与癌症中的激素信号传导
Adv Exp Med Biol. 2025;1464:279-307. doi: 10.1007/978-3-031-70875-6_15.
6
The sequence-structure-function relationship of intrinsic ERα disorder.内质网α受体固有无序的序列-结构-功能关系
Nature. 2025 Feb;638(8052):1130-1138. doi: 10.1038/s41586-024-08400-1. Epub 2025 Jan 8.
7
Exploring the Spatial Landscape of the Estrogen Receptor Proximal Proteome With Antibody-Based Proximity Labeling.采用基于抗体的邻近标记技术探索雌激素受体近端蛋白质组的空间景观。
Mol Cell Proteomics. 2024 Jan;23(1):100702. doi: 10.1016/j.mcpro.2023.100702. Epub 2023 Dec 19.
8
Palazestrant (OP-1250), A Complete Estrogen Receptor Antagonist, Inhibits Wild-type and Mutant ER-positive Breast Cancer Models as Monotherapy and in Combination.帕拉昔司他(OP-1250),一种完全的雌激素受体拮抗剂,作为单一疗法和联合疗法抑制野生型和突变型 ER 阳性乳腺癌模型。
Mol Cancer Ther. 2024 Mar 4;23(3):285-300. doi: 10.1158/1535-7163.MCT-23-0351.
9
Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus.孕激素受体激活功能 1 对于孕激素拮抗子宫内雌激素作用是必需的。
BMC Biol. 2022 Oct 5;20(1):222. doi: 10.1186/s12915-022-01410-3.
10
AR Structural Variants and Prostate Cancer.AR 结构变异与前列腺癌。
Adv Exp Med Biol. 2022;1390:195-211. doi: 10.1007/978-3-031-11836-4_11.